- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02683798
BEYOND Weight Loss Maintenance Study
Comparison of Two Weight Loss Maintenance Interventions in Counterweight Plus
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction: Long-term maintenance of non-surgical weight loss remains the most significant problem in obesity treatment. This study will compare the effectiveness of two different weight loss maintenance strategies used as part of the Counterweight Plus weight management programme. This study will also evaluate the behavioural impact of the Counterweight Plus interventions and include process evaluations and cost analysis.
Methods: 80 patients and 10 practitioners will be recruited into the study. Main inclusion criteria for patients are:
Completed Counterweight Plus, which includes 12-20 weeks total diet replacement (TDR), 8 weeks food reintroduction (FR) and achieved >10kg weight loss. All participants will be followed up for 18 months in total.
Results: The primary outcome of this study is the difference in weight change between the two groups at 6 months. Frequency of use of behavioural strategy will be quantified for both practitioners and patients during voice recorded consultations. The relationship between weight change and the use of behavioural strategy will be assessed.
Hypothesis: This study will establish if the novel intermittent use of formula diet strategy is more effective at preventing weight regain in comparison to usual care. It will also provide evidence of the frequency of use of behavioural strategies within routine Counterweight Plus delivery, as well as establishing the cost of the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Edinburgh, United Kingdom
- NHS Lothian
-
Glasgow, United Kingdom
- NHS Greater Glasgow and Clyde
-
Inverness, United Kingdom
- Nhs Highland
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Completed Counterweight Plus Total Diet Replacement and Food Reintroduction stages and achieved >10kg weight loss
Exclusion Criteria:
- People currently participating in another clinical research trial (not including BEYOND Weight Loss study)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Continuous energy restriction
1 x formula food (202-209kcal) meal replacement per day
|
1 x formula food (202-209kcal) meal replacement per day
|
|
Experimental: Intermittent energy restriction
4 x formula food (202-209kcal) total diet replacement per day, on 2 days per week
|
4 x formula food (202-209kcal) total diet replacement per day, on 2 days per week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight change
Time Frame: Baseline, 26 weeks
|
Difference between the two groups in change in body weight (kg)
|
Baseline, 26 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight change
Time Frame: Baseline, 52 weeks, 78 weeks
|
Change in body weight (kg)
|
Baseline, 52 weeks, 78 weeks
|
|
Acceptability
Time Frame: Baseline, 26 weeks, 52 weeks, 78 weeks
|
Number of clinic appointments attended as a proportion of the total number offered
|
Baseline, 26 weeks, 52 weeks, 78 weeks
|
|
Behavioural strategies
Time Frame: 78 weeks
|
Number of times behaviour change strategies used, assessed by qualitative analysis/coding of consultations
|
78 weeks
|
|
Eating behaviours
Time Frame: Baseline, 26 weeks, 52 weeks, 78 weeks
|
Change measured using Three Factor Eating Questionnaire- R18 (TFEQ-R18)
|
Baseline, 26 weeks, 52 weeks, 78 weeks
|
|
Quality of life
Time Frame: Baseline, 26 weeks, 52 weeks, 78 weeks
|
Change measured using EuroQoL-5D (EQ-5D)
|
Baseline, 26 weeks, 52 weeks, 78 weeks
|
|
Cost of interventions
Time Frame: 78 weeks
|
Difference between groups
|
78 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Lean, FRCPS, University of Glasgow
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GN15HN592
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Continuous energy restriction
-
Oslo University HospitalCompletedObesity | Dietary Modification | CVDNorway
-
Universidade do PortoUniversity of LisbonActive, not recruitingObesity | Weight LossPortugal
-
King's College LondonLighterLife (UK) LtdCompletedObesity, AbdominalUnited Kingdom
-
University of NottinghamCompletedWeight LossUnited Kingdom
-
Nanfang Hospital, Southern Medical UniversityCompletedObesity | Weight Loss | Time Restricted Feeding | Calorie RestrictionChina
-
Nanfang Hospital, Southern Medical UniversityCompletedNonalcoholic Fatty Liver DiseaseChina
-
Nanfang Hospital of Southern Medical UniversityCompletedNonalcoholic Fatty Liver DiseaseChina
-
Sahlgrenska University HospitalGöteborg UniversityNot yet recruitingThe Impact of a Weight Reduction Intervention on Clinical Outcomes in Patients With Obesity and COPDCOPD | Obesity &Amp; Overweight
-
King's College LondonMedical Research Council; Mars, Inc.CompletedAging | Cognitive DeclineUnited Kingdom
-
Imperial College LondonCompletedObesity | DiabetesUnited Kingdom